LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| BT-20 | QL-X-138 | 0.4960 |
| BT-20 | QL-XII-47 | 0.7617 |
| BT-20 | R406 | 0.0830 |
| BT-20 | Radicicol | 0.8310 |
| BT-20 | Sirolimus | 0.4602 |
| BT-20 | Ruxolitinib | 0.0801 |
| BT-20 | Saracatinib | 0.2283 |
| BT-20 | SB590885 | 0.0118 |
| BT-20 | Selumetinib | -0.0178 |
| BT-20 | Sigma A6730 | 0.1856 |
| BT-20 | Sorafenib | 0.1679 |
| BT-20 | SU11274 | 0.1301 |
| BT-20 | Fedratinib | 0.2364 |
| BT-20 | TGX221 | -0.0004 |
| BT-20 | Torin1 | 1.0131 |
| BT-20 | Torin2 | 1.1579 |
| BT-20 | Tozasertib | 0.9616 |
| BT-20 | Trametinib | 0.2698 |
| BT-20 | TWS119 | 0.1831 |
| BT-20 | Vemurafenib | 0.0878 |
| BT-20 | WH-4-025 | 0.5881 |
| BT-20 | Withaferin A | 0.6654 |
| BT-20 | WYE-125132 | 0.7925 |
| BT-20 | WZ-4-145 | 0.2649 |
| BT-20 | WZ3105 | 1.0806 |